RRCRANGE RESOURCES CORPORATIONMid cap · $8.54B · FY ending 2025-12-31
$36.24+2.11% · 2026-07-13 · EOD
57/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality89
margins & F-ScoreValue84
P/E 13.2 · 23% of 12-mo rangeMomentum47
golden · price below 200-daySmart Money9
selling · 0 funds · 0P/7S insidersMixed trendGolden crossBelow 200-day
vs S&P 500-1.7%
6-mo excess Trailing performance1M -7.4%
3M -15.4%
6M +6.9%
YTD +2.7%
1Y -3.8%
P/E vs its last 12 months (our price history): 12.0 low → 17.4 high
Current price sits at the 23th percentile of that window — near the bottom (cheaper). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Piotroski F7/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of ~21%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio13.0%
comfortable Shareholder yield1.0%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net selling0P / 7S insiders · 0 funds hold · 0 Congress buys
Recent insidersCline Brenda A · DirectorSELL$310,832
McDowell Erin W · SVP & General CounselSELL$396,000
Degner Dennis · Chief Executive Officer & PresSELL$693,150
DORMAN MARGARET K · DirectorSELL$542,268
CongressBrian BabinSELL2026-05-05
Bhealth · 73/100
Self-fundingSelf-funding — profitable · generates cash
- ●One-sided insider selling 7 insider sales and no open-market buys in the recent window.
- filingResults announced 8-K filed 2026-07-10 · source →
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.